The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
Utilization of Intracytoplasmic Sperm Injection ICSI (recommended) or ---Traditional IVF
Utilization of ejaculated or testicular sperm
Utilization of autologous or donor sperm
Utilization of donor oocytes
Utilization of gestational carrier
Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers
Parallel
Preimplantation genetic testing for aneuploidy (PGTA)
Other intervention24 chromosome screening for aneuploidy in the preimplantation embryo(blastocyst stage)
Ongoing Pregnancy Rate
The number of participants who experience an ongoing clinical pregnancy rate after the 1st embryo transfer.
Miscarriage Rate
Number of participants that experience a pregnancy loss after the 1st embryo transfer.
Click on the lead sponsor to view all of their trials.
Genomic Prediction Inc.
Lead sponsor
Boston IVF
Collaborator
